cells; KC þ M-MSC group) significantly increased the MI as a dose dependent manner. Bladder capacity and micturition volume of rats in the KC group decreased significantly compared with those in the sham group. However, these parameters were reversed after transplantation of M-MSCs with every cell dosage. The bladders in the KC group exhibited markedly increased infiltration of Toluidine blue stained mast cells and a higher number of TUNEL stained apoptotic cells, compared to the sham group. The administration of M-MSCs significantly reversed the infiltration of mast cell and apoptosis detected in the KC bladders. Furthermore, M-MSC therapy helped to prevent the bladder tissue fibrosis. The gene expression analyses indicated that several genes related to tissue fibrosis, including TGF-b1 and TGF-b2, were markedly upregulated in the KC bladder. However their expression was significantly suppressed by the administration of M-MSCs. Importantly, MMSCs ameliorated the bladder function of KC rats at a low dose (1 x 10 5 ) of cells for which BM-derived MSCs did not substantially improve aberrant bladder function.
CONCLUSIONS: This study demonstrates for the first time the therapeutic efficacy of hESC-derived M-MSCs on KC in rats. The injection of M-MSCs restores bladder function with superior efficacy compared to BM-derived MSCs by protecting against the abnormal alteration in mast cell infiltration, apoptosis and fibrotic damage. INTRODUCTION AND OBJECTIVES: Dysregulated regeneration is a hallmark in bladder pathobiology, including excessive muscle growth in partial bladder obstruction (PBO). However, rodent bladders show spontaneous regeneration following subtotal cystectomy (STC). Although BDNF well known to be upregulated during PBO, its role in regeneration is undisputed in the brain and other organs. We hypothesize that regulation of BDNF isoforms and doses is crucial for appropriate regeneration of bladder smooth muscle cell (BSMC).
METHODS: In Sprague-Dawley female rats, 75% of the bladder was removed (STC), while the remainder was closed with 7-0 polyglycolic acid sutures. The STC were compared to shams (n¼3,5 for 1, 7 wks), PBO (n¼5, at 7 wks) and cystotomy controls (n¼4,5 for 1, 7 wks). PBO was performed by tying a 8-0 silk ligature around 0.9 mm rod, which was then removed. Expression levels of BDNF isoforms, calponin and myosin were assayed by QPCR (delta-delta c(t) method) and indirect immunofluorescence. Scratch wounds were performed on monolayers of human BSMC in 12 well plates or chamber slides, utilizing a pipette tip and visualizing migration of cells by live cell microscopy. To test if scratch wounding increased BDNF expression, BSMC undergoing scratch or no wounds were assayed for BDNF isoforms by QPCR. To assess migration, scratch wounded BSMC were randomized to treatment with soluble BDNF receptor (TrkB) or vehicle. Exogenous BDNF was added to BSMC at 2.5, 5 and 10 ng/mL for 24-48 hours, followed by cell counting, immunofluorescence for calponin and phospho-histone3 and western blotting for myosin. RESULTS: Total BDNF was upregulated in STC (3.6-fold vs. sham at 7 weeks, p<0.035) vs PBO (>6-fold at 7 weeks, vs sham). The isoforms of BDNF were differentially regulated during STC compared to PBO, as variant1 was not upregulated in STC bladders, but was increased >370 fold during obstruction. In BSMC, 10 ng/mL BDNF decreased SMC markers calponinþmyosin, whereas at 2.5 ng/mL, it increased phosphoH3 expression, p<0.03. Similar to STC in vivo, scratch wounding increased BDNF expression mildly, at 2-fold, p<0.003. Scratch wound induced migratory behaviour in the BSMC and wound closure in the BSMC monolayers, leading to 70% wound closure at 16 hours. Migration was decreased 15% by soluble TrkB (p<0.02).
CONCLUSIONS: STC and scratch wound induce low level BDNF that increases migration and wound closure and was associated with regeneration. This work supports a role for differential effects of dose and isoforms of BDNF on bladders cells and tissue, which reflects the two-sided associations of BDNF in obstruction vs regeneration. METHODS: Female 10-week-old Sprague-Dawley rats were used for induction of chronic IC model. Chronic IC model was induced with single intravesical instillation of protamine sulfate (0.5ml of PS, 30mg/ml) and lipopolysaccharide (0.5ml of LPS, 2.25mg/ml) for 1 month. 35 rats were divided into five groups (N¼7): sham operation group, chronic IC receiving a single bladder submucosal injection of phosphate-buffered saline (20 mL, IC) or ICþ CHA1 (5 Â 10 5 cells/ 20mL, IV) or ICþ ADMSC (5 Â 10 5 cells/20mL, IV) and intravesical IALURILâ instillation (40mL, 40min). Four weeks after treatment, voiding spot was obtained and analyzed with Image J program. The bladder was harvested for histologic examinations and toluidine blue staining for mast cell. Microarray analysis was done. This study was approved by the Institutional Animal Care and Use Committee at our institution.
RESULTS: Rats in the IC group showed increased voiding frequency (3.5 vs 13.8) and decreased the spot size (3.6 vs 1.2 unit) compared with sham group. Significant improvement of voiding spot pattern in frequency (4.8 and 5.1) and size (3.2 and 3.5 unit) was observed in both CHA1 and ADMSC, however, there was no difference between the two groups and the result was comparable with IALURILâ group. Histological examination revealed a significant decrease in the total number of infiltrated mast cells in CHA1 and ADMSC group compared with the IC rats, and there was no difference between the two stem cell groups. Loss of urothelial integrity and increased neutrophil infiltration in IC group was restored both in CHA1 and ADMSC group. Microarray analysis using DAVID and KEGG pathway for CHA1 cells notes several enriched pathways including, various cellular response, metabolic process, nucleic acid binding and oxidative phosphorylation.
CONCLUSIONS: CHA1 and ADMCS showed comparable therapeutic efficacy in terms of improvement of voiding pattern and histological restoration in chronic IC model. And CHA1 MSC might produce therapeutic effects through multiple mechanisms. 
MP81-09 RECELLULARIZED ACELLULAR MATRIX VS NON-RECELULLARIZED ACELLULAR MATRIX IN A RAT MODEL FOR IN VIVO NEO-BLADDER REGENERATION
MARIA JOSE MORERA ESTEVE*, Mara Mellado-Lopez, Jeronimo Forteza, Victoria Moreno-Manzano, Cesar David VeraDonoso, Valencia, Spain
INTRODUCTION AND OBJECTIVES:
The use of decellularized natural matrices to recover a functional bladder has been shown to be the most appropriate source to reconstruct this organ. Our goal was to compare evolution of recellularized acellular matrix vs non-recelullarized matrix implanted in a rat model. METHODS: All experimental procedures were performed into consideration the ethical processes described by the animal committee of the center. Sprague-Dawley rats were used for the experiment. Here we compared the efficient and functional integration of a recellularized acellular matrix, previously seeded in vitro with human adipose tissue derived mesenchymal stem cells with a non-recelullarized matrix in a rat model of partial cystectomy and bladder substitution.
RESULTS: Relevant and significant anatomical differences were found few days after neo bladders implantation. The human ADSC containing matrix showed a significant recovery of mature urothelium measured as the positive reactivity to p63 at the transitional epithelium layers. The expression of the mesoderm marker, cytokeratin 7 was also significantly induced within the regenerated connective tissue. Interestingly a higher expression of smooth muscle actin was found at both, the internal and peripheral transversal and longitudinal smooth muscle layers in the hADSC-recellularized matrix. However, no significant induction in any of the transplanted groups, in comparison with native bladder, was found for CD31 expression, endothelium marker. The presence of the hADSC, by most probably the paracrine release of proregenerative factors, favors a faster and more efficient endogenous regeneration of the ectopic bladder allowing a faster voluntary urodynamic recovery within a more specialized an mature tissue.
CONCLUSIONS: Although bladder recellularization and urodynamic functional recovery have been successfully tested in small animals, and here we show the relevant benefits of the use of human ADSC on this regeneration process, more efficient procedures ex-vivo with a better understanding of the mechanisms involved of the ectopic transplanted cells is required in order to improve the tissue maturation in terms of peripheral nerve innervation and vascularization for a proper clinical translation Source of Funding: NONE
MP81-10 MOLECULAR CHARACTERIZATION OF THE MURINE URINARY BLADDER USING SINGLE CELL RNA SEQUENCING
Bernhard Kiss*, Aaron Kershner, Wan-Jin Lu, Philip Beachy, Stanford, CA INTRODUCTION AND OBJECTIVES: Bladder mucosa contains multiple clinically important cell types, including urothelial and mesenchymal cells, but these cells have not been rigorously characterized at the molecular level. Molecular identification of bladder mucosal cell types may identify pathways active in key cell subpopulations, including urothelial stem cells and tumor initiating cells, and may facilitate the development of approaches for the manipulations of these cells for therapeutic benefit.
METHODS: Single cell preparations of bladder mucosa from three-month-old male and female mice were subjected to scRNAseq using 10X RNAseq (6,257 unsorted single cells) and SmartSeq2 (1638 single cells) platforms. Three different cell populations were FACSisolated for Smartseq2 : 1) Lin-, Epcamþ, Sca-; 2) Lin-, Epcamþ, Scaþ; 3) Lin-, Epcam-, Scaþ. Clustering and transcriptome expression analyses utilized the Seurat package in R.
RESULTS: Both platforms revealed similar urothelial and mesenchymal cell populations, with slightly different cluster breakdowns between the two approaches. The unsorted 10X cell preparations contained minor subpopulations of endothelial cells and immune cells. The urothelial populations expressed high levels of the epithelial markers Cldn4 and Epcam and comprised four clusters in 10X and four clusters in SmartSeq2. The clusters expressing the highest levels of uroplakins (e.g., Upk3a and Upk1b) likely represent the most differentiated umbrella cells. Clusters expressing the highest levels of basal markers (e.g. Krt5, Cd44, Tp63 and Shh) likely represent basal cells. Clusters with lower expression of uroplakins in combination with lower expression of basal markers likely contain a mixture of basal and intermediate cells. Surprisingly, like the urothelial cells, the mesenchymal cells also displayed significant heterogeneity and comprised four distinct clusters. Whereas all mesenchymal cells expressed high levels of the stromal markers Dcn and Vim, expression of collagen genes varied between different stromal clusters and closely related clusters expressed similar levels of specific collagen subtypes (Col1a1 and Col1a2 vs Col8a1 and Col14a1). Differential expression of collagen genes thus accounts for some of the stromal heterogeneity.
CONCLUSIONS: Molecular characterization of the murine bladder using scRNAseq reveals an unreported heterogeneity of cells in the urothelium as well as in the stroma. Additional analyses based on these transcriptomes may reveal clinically important interactions between epithelia and stroma. , facilitate recovery from neuromuscular injuries. We hypothesized BDNF is a key factor in MSC secretions that enhances repairs of the neuromuscular continence mechanism in a dual injury SUI rat model. METHODS: MSCs were obtained from rats and BDNF expression was knocked down (KD) by lentiviral anti-BDNF shRNA, while a scrambled sequence was used as a control. Culture media containing secretions from the MSCs were collected to produce concentrated conditioned media (CCM), BDNF KD CCM, and
